Cannabinoids selective for the CB2 receptor
US6166066A · kind A · utility
28Cited by
6References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 1999 |
| Grant date | Dec 26, 2000 |
| Priority date | — |
| Expiry date | May 4, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/78
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel cannabinoids which are selective for the CB2 receptor. The novel cannabinoids comprise a substituted or unsubstituted tricyclic cannabinoid core and a substituted or unsubstituted C5-C8 carbocyclic ring, five to eight-membered heterocyclic ring or a seven to ten membered bicyclic ring system fused to the monhydroxylated phenyl ring of the cannabinoid core. Also disclosed are methods of suppressing the immune system in a subject by administering to the subject a (e.g. immunosuppressive amount) effective amount of a novel cannabinoid described above.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.